Valuation: Terumo Corporation

Market Cap 3,377B 21.46B 18.87B 17.84B 16.19B 30.4B 2,060B 30.57B 214B 82.52B 1,051B 80.55B 78.81B P/E 2027 *
17.7x
P/E 2028 * 17.5x
Enterprise Value 3,423B 21.75B 19.13B 18.09B 16.41B 30.81B 2,088B 30.99B 217B 83.64B 1,065B 81.65B 79.88B EV / Sales 2027 *
2.72x
EV / Sales 2028 * 2.5x
Free-Float
97.34%
Yield 2027 *
1.61%
Yield 2028 * 1.75%
1 day+0.26%
1 week+0.13%
Current month-9.48%
1 month-9.48%
3 months+1.36%
6 months+8.25%
Current year+0.33%
1 week 2,230
Extreme 2230
2,309.5
1 month 2,194.5
Extreme 2194.5
2,555
Current year 1,900
Extreme 1900
2,689
1 year 1,900
Extreme 1900
2,689
3 years 1,856
Extreme 1856
3,182
5 years 1,708
Extreme 1708
3,182
10 years 955
Extreme 955
3,182
Manager TitleAgeSince
Chief Executive Officer 62 31/03/2024
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 68 31/03/2022
Director/Board Member 63 20/06/2019
Director/Board Member 75 24/06/2020
Change 5-day change 1-year change 3-year change Capi.($)
+0.26%+0.13%-5.75%+14.94% 21.46B
-1.02%-3.38%-24.74%+3.44% 175B
-1.54%-2.82%-6.13%+12.57% 114B
-0.64%-4.46%-2.48%+66.93% 57.98B
-1.05%-0.51%-1.05%-29.58% 50.07B
-1.00%+0.37%+14.24%+51.55% 50.13B
-0.62%-3.42%+30.11%-7.32% 32.71B
-0.61%+1.50% - - 30.77B
-0.71%+0.61%+43.42%-0.49% 26.44B
-0.09%+4.75%+26.40%-4.34% 23.96B
Average -0.74%+1.66%+8.22%+11.97% 58.27B
Weighted average by Cap. -0.97%-0.09%-3.38%+12.66%

Financials

2027 *2028 *
Net sales 1,261B 8.01B 7.04B 6.66B 6.04B 11.35B 769B 11.41B 79.75B 30.8B 392B 30.07B 29.42B 1,342B 8.52B 7.5B 7.09B 6.43B 12.07B 818B 12.14B 84.87B 32.78B 417B 32B 31.31B
Net income 191B 1.21B 1.06B 1.01B 913M 1.71B 116B 1.72B 12.05B 4.65B 59.29B 4.54B 4.45B 193B 1.22B 1.08B 1.02B 924M 1.74B 118B 1.75B 12.2B 4.71B 59.99B 4.6B 4.5B
Net Debt 45.99B 292M 257M 243M 220M 414M 28.05B 416M 2.91B 1.12B 14.31B 1.1B 1.07B -26.39B -168M -147M -139M -126M -238M -16.1B -239M -1.67B -645M -8.21B -630M -616M
Logo Terumo Corporation
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
Employees
30,591
Date Price Change Volume
29/09/26 JP¥2,277.50 +0.26% 4,840,400
28/09/26 JP¥2,289.50 -0.30% 5,905,500
25/09/26 JP¥2,296.50 +0.97% 5,424,500
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
2,289.50JPY
Average target price
3,110.00JPY
Spread / Average Target
+35.84%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4543 Stock